|
|
Clinical Efficacy of Nicergoline Combined with Donepezil in the Treatment of Elderly Hypertensive Patients with Dementia |
ZHANG Miao, CHEN Jing |
Department of Neurology, Shaanxi Provincial Rehabilitation Hospital, Xi'an Shaanxi 710000 |
|
|
Abstract 【Objective】To explore the efficacy of Nicergoline combined with Donepezil in the treatment of elderly patients with hypertension and dementia. 【Methods】A total of 80 elderly patients with hypertension and dementia admitted to our hospital were divided into two groups using odd even number lottery method, with 40 cases in each group. Both groups of patients received conventional antihypertensive therapy with amlodipine and donepezil, while the observation group was treated with combination therapy with Nicergoline for one month. The 24-hour mean systolic blood pressure (24hSBP) and 24-hour mean diastolic blood pressure (24hDBP), left ventricular ejection fraction (LVEF), nitric oxide (NO), endothelin (ET), acetylcholine (ACh) levels, as well as the scores of the Mini Mental State Scale (MMSE) and Clinical Idiotic Rating Scale (CDR) were compared between two groups of patients before and after treatment. 【Results】After treatment, the 24-hour SBP and 24-hour DBP of the observation group were lower than those of the control group (P<0.05); The LVEF, serum NO, and Ach levels in the observation group were higher than those in the control group (P<0.05), while the serum ET levels in the observation group were lower than those in the control group (P<0.05); After treatment, the MMSE score of the observation group was higher than that of the control group (P<0.05), while the CDR score was lower than that of the control group (P<0.05). 【Conclusion】The combination of Nicergoline and Donepezil in the treatment of elderly hypertensive patients with dementia helps to lower blood pressure, improve cardiac function indicators, and serum NO, ET, and ACh levels, effectively improving the patient's intelligence level, and achieving satisfactory clinical efficacy.
|
Received: 21 October 2022
|
|
|
|
|
[1] 王凌玲,林伟青,蒋玲霞,等. 中医药辨证治疗H型高血压合并血管性痴呆的疗效[J].中国老年学杂志,2022,42(6):1281-1284. [2] 弓少华, 郭红, 刘幼华,等. 老年痴呆患者家庭照顾者虐待行为及影响因素的系统评价[J].中国老年学杂志, 2021, 41(7):7-12. [3] SCHELTENS P, DE STROOPER B, KIVIPELTO M, et al.Alzheimer's disease[J].Lancet,2021,397(10284):1577-1590. [4] 杨丽超,李银萍,杨蓉. 尼麦角林联合降纤酶治疗短暂性脑缺血发作的临床研究[J].现代药物与临床,2020,35(1):65-69. [5] 吴士玲. 老年痴呆症防治指南[M].天津:天津科学技术出版社, 2013:18-19. [6] NARANG A, ADDETIA K. An introduction to left ventricular strain[J].Curr Opin Cardiol,2018,33(5):455-463. [7] AGARWAL M, THAREJA N, BENJAMIN M,et al. Tyrosine kinase inhibitor-induced hypertension[J].Curr Oncol Rep,2018,20(8):65-74. [8] YANG Y H, WU M N, CHOU P S,et al. Longitudinal neuropsychological outcome in Taiwanese Alzheimer's disease patients treated with medication[J].Curr Alzheimer Res,2018,15(5):474-481. [9] 魏玮,谢晓琳,李学盈,等. 老年痴呆患者炎性因子、血糖、血压与认知功能的相关性[J].中国老年学杂志, 2020, 40(24):3-7. [10] REVI M. Alzheimer's disease therapeutic approaches[J].Adv Exp Med Biol,2020,1195(25):105-116. [11] SENGOKU R. Aging and Alzheimer's disease pathology[J].Neuropathology,2020, 40(1):22-29. [12] 王剑, 李燕秋, 唐刚. 培哚普利叔丁胺片和盐酸贝那普利片对急性心肌梗死患者左心室重构的影响[J].成都医学院学报, 2021, 16(4):5-9. [13] 罗瑶,柴坷,程雅琳,等.左心室射血分数改善的心力衰竭患者的临床特征分析[J].中华心血管病杂志,2021,49(4):333-339. [14] 陈颖哲, 刘巍, 张天宇,等. 针刺泻法对高血压中医证候及血清NO、ET-1水平的影响[J].中西医结合心脑血管病杂志, 2021, 19(2):4-8. [15] 毛礼阳, 邵春阳. 尼莫地平联合尼麦角林治疗阿尔茨海默病患者的效果及对血清E2、HIF-1α水平的影响[J].卒中与神经疾病, 2019, 26(3):313-316. |
|
|
|